Editas Medicine Inc (NAS:EDIT)
$ 5.3 -0.13 (-2.39%) Market Cap: 435.86 Mil Enterprise Value: 173.83 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 52/100

Q1 2021 Editas Medicine Inc Earnings Call Transcript

May 05, 2021 / 12:00PM GMT
Release Date Price: $34.72 (+0.17%)
Operator

Good day, and thank you for standing by. Welcome to the Q1 2021 Editas Medicine Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your first speaker today, Ron Moldaver, Investor Relations. Please go ahead.

Ron Moldaver;Investor Relations

Thank you, Juliann. Good morning, everyone, and welcome to our first quarter 2021 conference call. Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. A replay of today's call will be available on the Investors section of our website approximately 2 hours after its completion. After our prepared remarks, we will open the call for Q&A.

As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot